Department: Medicinal Chemistry, Nanotechnology, Organic Chemistry
University: Taipei Medical University
Hsu-Shan Huang received his B.Pharm degree from School of Pharmacy, National Defense Medical Center (NDMC) in 1985 and master degree in 1987. He then earned his Dr. rer. nat.in 1996 at University of Regensburg, Germany. He went back to Taiwan and joined School of Pharmacy, NDMC as an Associate Prof. in 1997, and then promoted to Professor in 2005. From 2000-2001, he has been visiting scientist at Institute of Pharmaceutical Chemistry, University of Muenster, Germany. From 2006 to 2007, he has been visiting scientist at The Scripps Research Institute (La Jolla, San Diego, California, USA).After being promoted to full professor, he worked as a Dean of School of Pharmacy, and Head of Research and Development at NDMC (2008-2012). In 2013, he was head of Department of Pharmacy Practice, Tri-Service General Hospital/NDMC. In Feb. 2014, he moved to Taipei Medical University as Professor of Cancer Biology and Drug Discovery. In 2014, he moved to the Taipei Medical University, College of Medical Science and Technology as Professor of Oncology Research, managing two research centers in immunology and oncology. He is now responsible for the research activities (drug discovery and development) of the TMU.
His research mainly focuses on medicinal chemistry and biology of medicinally important natural products, and heterocyclic small molecules; the discovery of new synthetic methodologies; the development of novel anticancer agents with novel mechanisms of action and promising anti-inflammatory small molecules. His research also focuses on formulation and evaluation of targeted drug delivery systems for anticancer agents and anti-inflammatory agents; nanomedicines and magnetic small molecules.His research interests also extend over a wide range of biologically active molecules, mostly anticancer agents, such as small molecules and natural products
Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: email@example.com
Copyright © 2020 Boffin Access Limited.